Nahdi Medical Company Nahdi Medical Company

Nahdi Medical Company

4164

Clasificación en acciones #4856
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Precio por acción
$23.42
Capitalización bursátil
$3.05B
Cambio (1 día)
-0.45%
Cambio (1 año)
-27.09%
País
SA
Comercio Nahdi Medical Company (4164)

Categoría

Healthcare
Ganancias de Nahdi Medical Company (4164)
Ganancias en Jun 2026 TTM: $217.74M
Secondo gli ultimi rapporti finanziari di Nahdi Medical Company, gli utili attuali della società sono $217.74M. Nel 2023, la società ha registrato un utile di $251.81M, un aumento con respecto a agli utili del 2022, che erano di $249.53M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Nahdi Medical Company desde 2017 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $217.74M -1.98%
2024 $222.14M -11.78%
2023 $251.81M 0.91%
2022 $249.53M 9.27%
2021 $228.35M -4.23%
2020 $238.42M 16.36%
2019 $204.91M 20.34%
2018 $170.27M -15.09%
2017 $200.53M 0.00%
Ganancias de empresas similares o competidoras